These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17009930)

  • 1. Antimicrobial development and the risk-benefit assessment: recent adverse events and their implications.
    Tillotson GS; Blondeau JM
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):515-7. PubMed ID: 17009930
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinued drugs in 2006: anti-infectives.
    Ryder NS
    Expert Opin Investig Drugs; 2007 Dec; 16(12):1867-78. PubMed ID: 18041997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The innate immune system: a repository for future drugs?
    Sambhara S; Lehrer RI
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):1-5. PubMed ID: 17266447
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial agents and their adverse effects.
    Pa Med; 1966 Mar; 69(3):33-5. PubMed ID: 5905723
    [No Abstract]   [Full Text] [Related]  

  • 5. Principal toxic, allergic, and other adverse effects of antimicrobial agents.
    Md State Med J; 1965 Nov; 14(11):48 passim. PubMed ID: 5832380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adverse reactions of medicines. 4. Adverse reactions to anti-infective agents. (2)].
    Seki T
    Kango; 1974 Sep; 26(9):108-9. PubMed ID: 4498617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adverse effects of drugs. Adverse effects of anti-infective agents].
    Seki T
    Kango; 1974 Aug; 26(8):108-9. PubMed ID: 4499311
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of concentrated trisodium citrate catheter locks.
    Polaschegg HD; Sodemann K
    Nephrol Dial Transplant; 2008 Dec; 23(12):4075; author reply 4075-6. PubMed ID: 18772176
    [No Abstract]   [Full Text] [Related]  

  • 9. Proarrhythmic potential of antimicrobial agents.
    Simkó J; Csilek A; Karászi J; Lorincz I
    Infection; 2008 Jun; 36(3):194-206. PubMed ID: 18454341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial-associated risk factors for Clostridium difficile infection.
    Owens RC; Donskey CJ; Gaynes RP; Loo VG; Muto CA
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S19-31. PubMed ID: 18177218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing individual benefit against public health risk: the impact of cotrimoxazole prophylaxis in HIV-infected patients on antimicrobial resistance.
    Hamer DH; Gill CJ
    Am J Trop Med Hyg; 2008 Sep; 79(3):299-300. PubMed ID: 18784218
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired QT prolongation.
    Cahoon WD
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):30-3. PubMed ID: 19261141
    [No Abstract]   [Full Text] [Related]  

  • 13. The trials and tribulations of drug development for functional gastrointestinal disorders.
    Chang L
    Neurogastroenterol Motil; 2008 May; 20 Suppl 1():130-8. PubMed ID: 18402650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic area influences drug development costs.
    Frantz S
    Nat Rev Drug Discov; 2004 Jun; 3(6):466-7. PubMed ID: 15214327
    [No Abstract]   [Full Text] [Related]  

  • 15. Complications of antimicrobial therapy.
    Turck M
    Del Med J; 1971 Nov; 43(11):302-7. PubMed ID: 5122240
    [No Abstract]   [Full Text] [Related]  

  • 16. Telavancin: a new lipoglycopeptide with multiple mechanisms of action.
    Kanafani ZA
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):743-9. PubMed ID: 17140351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving polymorph selectivity in the crystallization of pharmaceutical solids: basic considerations and recent advances.
    Reutzel-Edens SM
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):806-15. PubMed ID: 17117688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic and endocrine effects of antimicrobial drugs].
    Zarković M; Cirić J
    Acta Chir Iugosl; 1995; 42(2 Suppl 2):57-63. PubMed ID: 9471849
    [No Abstract]   [Full Text] [Related]  

  • 19. An in vitro assessment of bioadhesive zinc/carbomer complexes for antimicrobial therapy within the oral cavity.
    Keegan G; Smart J; Ingram M; Barnes L; Rees G; Burnett G
    Int J Pharm; 2007 Aug; 340(1-2):92-6. PubMed ID: 17452085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-related risk factors for postoperative adverse events.
    Moonesinghe SR; Mythen MG; Grocott MP
    Curr Opin Crit Care; 2009 Aug; 15(4):320-7. PubMed ID: 19512920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.